Literature DB >> 15241524

[Iloprost. Pharmacology and clinical application during surgery].

W Wilhelm1, U Grundmann.   

Abstract

Iloprost is a long-acting prostacyclin analogue with potent vasodilating properties. When applied per inhalation, iloprost rapidly and remarkably reduces pulmonary vascular resistance and thereby pulmonary artery pressure for approximately 60-120 min. In addition, if iloprost is inhaled and not infused, major systemic side-effects such as a significant reduction of the systemic arterial pressure can mostly be circumvented. Inhaled iloprost can be applied by means of ultrasound or by oxygen flow with both techniques being available for intensive care ventilators. For use in the anaesthesia circuit a special construction was built.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15241524     DOI: 10.1007/s00101-004-0728-7

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  5 in total

1.  Intraoperative inhalation of the long-acting prostacyclin analog iloprost for pulmonary hypertension.

Authors:  Frank Langer; Wolfram Wilhelm; Dietmar Tscholl; Rene Schramm; Henning Lausberg; Olaf Wendler; Hans-Joachim Schäfers
Journal:  J Thorac Cardiovasc Surg       Date:  2003-09       Impact factor: 5.209

2.  Pharmacokinetics and pharmacodynamics of the prostacyclin analogue iloprost in man.

Authors:  W Krause; T Krais
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

3.  Pharmacokinetics and pharmacodynamics of radio-labeled iloprost in elderly volunteers.

Authors:  W Krause; T Krais
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

4.  Treatment of a case of acute right heart failure by inhalation of iloprost, a long-acting prostacyclin analogue.

Authors:  F Langer; O Wendler; W Wilhelm; D Tscholl; H J Schäfers
Journal:  Eur J Anaesthesiol       Date:  2001-11       Impact factor: 4.330

5.  Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.

Authors:  H Olschewski; D Walmrath; R Schermuly; A Ghofrani; F Grimminger; W Seeger
Journal:  Ann Intern Med       Date:  1996-05-01       Impact factor: 25.391

  5 in total
  1 in total

1.  Aerosol delivery by an ultrasonic nebulizer during different mechanical ventilation settings in a lung model--a pilot study.

Authors:  Michael Winterhalter; Michael Bund; Nawid Khaladj; Christian Hagl; Andre Simon; Ludwig Hoy; Siegfried Piepenbrock; Niels Rahe-Meyer
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.